å»çæ©åšå ¬è¡šãããæŽå¯
黿°æ¯ç§çšãã³ãããŒã¹ã¯ããã£ããã£ã®æºåãçå ã®æºåããã«ã€é€å»ãå åŸãªã©ã®ããŸããŸãªæé ãå®è¡ããããã«æ¯ç§å»ã«ãã£ãŠããã€ã¹ã§ãã é»åãã³ã¿ã«ãã³ãããŒã¹ã¯ãã®ã¢ãšã·ã£ããã«åãä»ããããé»åã¢ãŒã¿ãŒãå©çšãããããã®ã®ã¢ã¯ããŒ(å®éã®åæãå®è¡ããéšå)ã§åãä»ããããŸãã äžæ¹ã空æ°ã«ãã£ãŠé転ãããæ¯ç§handpieceã¯ã¿ãŒãã³ãåãå§çž®ç©ºæ°ã§ãæ£ãåããŸãã ãããã®é»æ°handpiecesã«äžè²«ããé床ããã³ãã«ã¯ã®ãããªç©ºæ°é転ãããæ¯ç§handpiecesäžã®è€æ°ã®å©ç¹ããããŸãã é»åæ¯ç§ãã³ãããŒã¹ã¯ãé床å¶åŸ¡(100ã2ã00000)ãšé«ãã«ã¯(ã°ãªãã¿ãŒåæå)... ãã£ãšèŠã
Intraosseous Infusion Device Marketã¯ãUSD 1,112.1ã§è©äŸ¡ããããšæšå®ãããŸãã 2025幎ã®Mnã¯USD 1,607.0ã«éãããšäºæ³ããã 2032幎ã«Mnã2025幎ãã2032幎ãŸã§ã®5.4%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºãã°ããŒãã«ã»ã€ã³ãã©ããŒã¹ã»ã€ã³ãã¥ãŒãžã§ã³ã»ããã€ã¹ã»ããŒã±ããã®ã¢ããªã¹ãã»ãã¥ãŒ:Intraosseousæ³šå ¥ã¯ã®ããã«å©èšããŸã ã«ãŒãã£ãªãã«ã¢ã³ åšèŸºã®éèã¢ã¯ã»ã¹ã倱æãããšãã«èç, äºæž¬æéã«ããã£ãŠãäžççãªç¡è»éæ³šå ¥ããã€ã¹åžå ŽãåŸæŒãããããã«èšç»ãããŠãã. æ·±å»ãªäºæ ãå¿è¡ç®¡é害ãè¥æºãã... ãã£ãšèŠã
äžççãªãã€ãªãµãŒãžãªãŒåžå Žã¯ãUS$13,887.5 Mn2021幎ã¯äŸ¡å€ã®äŸ¡å€ã«éããèŠéãã§ãUS$ 22,212.9 ã¡ãŒãã«ã«ãã£ãŠ2028幎ãåãåãã6.9%ã®CAGRéã®è·é¢2022幎ã2028幎ãåãåãã äžççãªãã€ãªãµãŒãžãªãŒåžå Žã¯ãåªå é äœã®äžæã«ãã匷ãæé·ãçµéšããŠããŸã å¿èè¡ç®¡ äžçåå°ã®çŸæ£ããã³æé·ã®æ¿ãã人å£ã ãŸããå é²çãªæè¡ããŒã«ãè£ çœ®ã®å°å ¥ã®å¢å ãå¥åº·æèã®åäžãå»çã€ã³ãã©ã®æŽåãæåŸ ãããåžå Žã®æé·ãå éããŸãã ããããªããããã€ãªæè¡ãæè¡ã®è²»çšãªã©ã人ã ã®æèã®æ¬ åŠãªã©ã®èŠå ã¯ãåžå Žæé·ã劚ããããšãæåŸ ãããŸããã°ããŒãã«ãã€ãªãµãŒãž... ãã£ãšèŠã
äžççãªå»çã€ã¡ãŒãžã³ã°æ©åšåžå Žã¯ãè©äŸ¡ããããšæšå®ããã 45.0åç±³ãã« ãåãåãã 2023幎 å±ç€ºäºå® ã«ã°ã¬ äºå ±æéäžã® 5.3% (2023-2030).ã°ããŒãã«å»çã€ã¡ãŒãžã³ã°æ©åšåžå Žã«é¢ããã¢ããªã¹ãã®æèŠ:èºã€ã¡ãŒãžã³ã°ã«äœ¿çšãããç£æ°å ±é³Žã€ã¡ãŒãžã³ã°ã·ã¹ãã ã®éçºã®ããã®åžå Žãã¬ã€ã€ãŒã«ããæè¡æ®åãäºæž¬æéã«ããã£ãŠåžå Žã®æé·ãä¿ãããšãæåŸ ãããŸãã ããšãã°ã2021幎12æããã€ãã«æ ç¹ã眮ãã³ã³ã°ãããªããã®ã·ãŒã¡ã³ã¹AGã¯ããªãã€ãªå·ç«å€§åŠå»åŠéšãšå·¥åŠç§ã®ç ç©¶è ãšå ±åã§æ°ããMRI(ç£æ°å ±é³Žã€ã¡ãŒãžã³ã°)æè¡ãéçºããŸããã æ°ããMRIã0.55T MA... ãã£ãšèŠã
ã°ããŒãã«ãã©ãã°ããã€ã¹ã³ã³ãããŒã·ã§ã³è£œååžå Žã¯ã ã¢ã¡ãªã«ãã« 150.23ã®ç¹é· è³æ¬é çŸäžå ãåãåãã 2023幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠7.6% äºå ±æéäž (2023-2030).ã¢ããªã¹ãã®ãã¥ãŒ ã°ããŒãã«ãã©ãã°ããã€ã¹ã³ã³ãããŒã·ã§ã³è£œååžå Ž: : :äžççãªè¬ç©è£ 眮ã®çµã¿åãã補ååžå Žã¯ãè¬ç©åžéã¹ãã³ããå«ãæ§ã ãªè£œåã«ãã£ãŠç¹åŸŽä»ããããŸãã æ³šå ¥ãã³ããåžå ¥åšããã³ ã€ã³ã·ã¥ãªã³ã®ãã³ä»è ã®éã§ã ãããã®é©æ°çãªè£œåã¯ãæ£è ã®ææãæ¹åããå©äŸ¿æ§ãé«ããæšçãããå»è¬åã®é ä¿¡ãæäŸããŸãã åžå Žã¯ãç ç©¶éçºã«ãããéèŠãªæè³ãç®æããæ°ããçµã¿åãã... ãã£ãšèŠã
å»ççšã¬ã¹åæåšã¯ãããŸããŸãªå»ççæ³ã§äœ¿çšãããããŸããŸãªã¬ã¹ã远跡ããããã«ç é¢ã®èšå®ã§äœ¿çšãããŸãã ãããã®å»åŠã®ã¬ã¹ã¯é žçŽ ãäºé žåççŽ ãçªçŽ ã®äºé žåç©ããã³å»åŠã®ç©ºæ°ãå«ãã§ããŸãã å»åŠã®ã¬ã¹ã¯ãããèªç¶ãªççåŠçãªéå£ãéããŠå®¹æãªæµžéãå¯èœã«ããã®ã§æ²»çäžã®å©ç¹ããããŸãã ç°ãªãã¬ã¹ã¯ãããŸããŸãªç æ°ã®ç¶æ ã®ããã®ç°ãªãæ²»ç广ãæã£ãŠããŸãã å»ççšã¬ã¹ã¯ãåžå ¥ãé£²çšæ°ŽçŽ æ°Žãããã³æ°ŽçŽ é£œåå¡©çŽ ãšã®æ³šå°ãéããŠæäžããããšãã§ããŸããã·ã¹ãã ã®ç®¡çåŸãæ£è ã®ç¶æ ãå®å®ããŠç¶æãããããã«ããããã®ã¬ã¹ã®æ¿åºŠã枬å®ããåæããŸãã å»åŠã®ã¬ã¹ã®æ€å åã¯ææã¡åãèªåã§ããããã... ãã£ãšèŠã
Hemostatsãå¥åhemostaticã¯ã©ã³ããåèã®éåãŸãã¯ããŒãã¯åºè¡ãå¶åŸ¡ããããã«å€ç§ããã·ãŒãžã£ã§äœ¿çšãããå€ç§çšå ·ã§ãã ãã¢ã¹ã¿ããã¯ãåºè¡çäŸã®è¡æµã管çããããã«ãå°åã®è¡ç®¡ãã¯ã©ã³ãããããã«èšèšãããŸããã ãããã®è£ 眮ã¯ãŸãå·ã®ééã®å€ç§ããã·ãŒãžã£ã®éã«è¡šé¢çãªfasciaãæ¡ããä¿éããã®ã«äœ¿çšãããŠããŸãã ãã³ãžãšãªã³ã°ãä»ãããã¢ã¹ã¿ããã¯ãã¯ãã¿ã«äŒŒãŠããŸãã ãããã®å𿢰ã¯ç· ããéåã®é¡ãäžç·ã«æ¥ãã¯ã©ã³ãã®ããã«äœ¿çšããããã¿ãããšããŠç¥ãããŠããé ã®ã¡ã«ããºã ãæã£ãŠããŸããããã¯è¡ç®¡ã®éå£éšãå¯å°ããã®ã«åœ¹ç«ã¡ãŸãã å€ãã®å Žåããã¢ã¹ã¿ãã... ãã£ãšèŠã
Aortic aneurysm 㯠aorta ãæ¡å€§ããå»åŠã®ç¶æ ã§ãã è ¹éšãšèžéšã¯ãåèç€ã®2ã€ã®ã«ããŽãªã§ãã ãããã®æ¡ä»¶ã¯ãè ¹çãäœè¡å§ãæèã®åªå€±ããŸãã¯æ»äº¡ã«ã€ãªããããšãã§ããŸãã Endovascularã®aneurysmã®ä¿®ç(EVAR)ã¯è ¹éšããã³thoracicã®ãªãŒã©ã«ã¹ã ãæ±ãæäœã®äŸµè¥²çãªå€ç§æ¹æ³ã§ãã ããã¯ã®ããã®å€ç§ãéãã代ããã§ã è ¹éšåèç€ (AAA) æ¯èŒçå®å šãã€æéã®ãããæéãç¯çŽããã ããããªããããã¹ãŠã®æ£è ã¯ãEVARã«é©ããŠããããã§ã¯ãããŸããã ãŸããEVARãçšããè èã®ä»è¿ãè èã®çç¶ãæ²»çããããšã¯å°é£ã§ããæç¶çãªè¡ç®¡ã®... ãã£ãšèŠã
ã¬ã€ãã¯ã€ã€ãŒã¯ãç æ°ã®èåšã«çœ®ãããã®ã«ããŒãã«ãå°ãæè»ã§èã管ã§ãã ã¬ã€ãã¯ã€ã€ãŒã¯ã¿ãŒã²ãã容åšãååã®æå®³ãéããæ£è ã«æ±ºå®çãªinterventionalçæ³ãæäŸããã®ã«äœ¿çšãããŠããŸãã ã¬ã€ãã¯ã€ã€ãŒã¯ãæ£ç¢ºã§å¹æçãªçµæãã¬ã³ããªã³ã°ããèœåã®ããã«ãæå°éã®äŸµè¥²æè¡ã®åéã§äžå¯æ¬ ãªçšéãšè¡ç®¡ä»å ¥ã®éèŠãªã³ã³ããŒãã³ãã§ãã ã¬ã€ãã¯ã€ã€ãŒã¯ããŸããŸãªèšåºæç€ºã®å¿ èŠæ§ã®ç°ãªã£ãè£ çœ®ã®ç¹åŸŽãšããŠè€æ°ã®ã¿ã€ãã§ãã ç¹å®ã®æ¡ä»¶ã®ããã®é©åãªã¬ã€ãã¯ã€ã€ãŒã¯è£ 眮é éãæ¹åããäº€å·®ã®æåãé«ããè²»çšãå¶éãã管ã®å·å®³ã®å±éºãå¶éã§ããŸãã å°ç·ã¯ãäž»ã«ãè¡ç®¡ãæå·ãé²ãããã匟æ§... ãã£ãšèŠã
å»åŠã®ããªããã¯ã€ã³ãã©ã³ãã¯ãèªç¶ã®äžã§èŠã€ãã£ãçç©åŠçæ¹æ³ãšã·ã¹ãã ã®å©ããåããŠäœãããç¹æ®ãªã¿ã€ãã®ããã€ã¹ã§ã æ¢ç¥ã®äŸã¯ãã³ã¯ã¬ã¢ã€ã³ãã©ã³ãã人äœã«æ³šå ¥ãããè©æ¬ºã®äººã ã®ããã®è£ 眮ã§ãã å»åŠã®bionicæ³šå ¥ã¯æ£åžžãªãã㣠ãªã«ã¬ã³ãšåãæ©èœããŸãã ãã€ãªãã¯ã¹ã¯ãå®éã«çç©åŠãšé»åæ©åšã®çµã¿åããã§ãã ã€ã³ãã©ã³ãå»çãã€ãªããã¯ã€ã³ãã©ã³ãã®ããããããŒãžã§ã³ã®ä»£ããã«ãããè¯ãæ©èœãæäŸããŸãã å»ççšãã€ãªããã¯ã€ã³ãã©ã³ãã¯ããªãªãžãã«ã®æ©èœãæ£ç¢ºã«å®è¡ãããããããããããã«è¯ãããããšãã§ããŸããå»åŠã®bionicã®æ³šå ¥ã¯ç æ°ããã³å·å®³ã«ãã人åšãå·ã€ããšã... ãã£ãšèŠã
æ°ç®¡åéãã¥ãŒãåžå Žã補åã¿ã€ãå¥ïŒã«ãä»ãæ°ç®¡åéãã¥ãŒããã«ããªãæ°ç®¡åéãã¥ãŒããæçªãã¥ãŒããããã³èª¿æŽå¯èœ/ç¹æ®ãã¥ãŒãïŒãææå¥ïŒPVCãã·ãªã³ãŒã³ããã®ä»ïŒãæ£è ã¿ã€ãå¥ïŒæäººããã³å°å /æ°çå ïŒãçšéå¥ïŒé·æææ°ãç·æ¥æ°é管çãæ ¢æ§çŸæ£ç®¡çãããã³è¡åŸæ°éãµããŒãïŒããšã³ããŠãŒã¶ãŒå¥ (ç é¢ã倿¥æè¡ã»ã³ã¿ãŒãåšå® å»çæœèšãªã©)ãå°çå¥ (åç±³ãã©ãã³ã¢ã¡ãªã«ããšãŒããããã¢ãžã¢å€ªå¹³æŽãäžæ±ãã¢ããªã«)... ãã£ãšèŠã
ã©ãã©ããªãŒã»ãªãŒãã¡ãŒã·ã§ã³ã¯ãå»çæ€æ»ãšããã»ã¹ãæ¹åããããã«ãã©ãã©ããªãŒã«ãããæè¡ãéçºãæé©åããåŠéçã¢ãããŒãã§ãããã©ãã»ãªãŒãã¡ãŒã·ã§ã³ã¯ãæœåšçã«å±éºã§ãšã©ãŒã®èµ·ãããããã£ãæåã¹ããããèªååãããããã»ã¹ã«çœ®ãæãããã©ãã®èªååã¯ãåæåãšåæåŸã®æ®µéã«åããããšãã§ãããæ€æ»å®€ã®èªååã¯ãç¡é§ãçããããå°ãªã詊è¬éã䜿çšããããšã§ãããã»ã¹ã®å šäœçãªå¹çãåäžããããåæåã®èªååã§ã¯ããµã³ãã«/詊è¬ã®ä¿ç®¡ããæ·»å ã調補ãŸã§ã®ãã¹ãŠã®æ®µéãå«ãŸãããåæå段éã§ã®ãšã©ãŒã¯ãä¿ç®¡äžè¯ã誀ã£ã容éããã®ä»ãªã©ã®èŠå ã§æå€§70%ã«éããã äžçã®ã©ããªãŒãã¡ãŒã·... ãã£ãšèŠã
å ç«æž¬å®åš åžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033幎äžççãªå ç«æž¬å®åšåžå ŽèŠæš¡ã¯æšå®ããã 2026幎ã®USD 3.5åã§è©äŸ¡ãããUSD 6.8ã«éããèŠèŸŒã¿ 2033幎10æã9.3%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€º 2026幎ïœ2033幎ãããã£ãŒã«å ç«æž¬å®åšåžå Žã¯äžæã®åªå é äœã«ãã£ãŠé転ãããŸã çãå¿è¡ç®¡ãå«ãææçããã³æ ¢æ§çŸæ£ é害ãšç³å°¿ç ã®ã¡ãªã¿ã¹ã æ©æããã³æ£ç¢ºã®ããã®æé·ã®èŠæ± ç æ°ã®èšºæã¯é«åºŠã®å ç«åŠã®æ¡çšãå éããŸã èšåºå®éšå®€ã®æè¡ã æè¡é©æ°ãªã© ãªãŒãã¡ãŒã·ã§ã³ãé«ã¹ã«ãŒããã ã·ã¹ãã ãããã³é«ããããæåæ§ã¯ãããŸã ãã¹ãã®å¹çããã³ä¿¡é Œæ§ãæ¹å... ãã£ãšèŠã
ä¹±çšè©Šéšè£ 眮ã®åžå ŽèŠæš¡ãšäºæž¬ã®ããã®è¬ - 2026幎ïœ2033å¹Žä¹±çšæ€æ»è£ 眮åžå ŽèŠæš¡ã®ã°ããŒãã«å»è¬åã¯ã 2026幎ã®USD 1.8åã§è©äŸ¡ãããUSD 3.2ã«éãããšäºæž¬ããã 2033幎10æãååç©ã®å¹Žéæé·ç(CAGR)ã®ç»é² 2026幎ãã2033幎ãŸã§ã®äºæž¬æéã®8.5%ããããã£ãŒã«ä¹±çšãã¹ãè£ çœ®åžå Žã®è¬ã¯äžæã«ãã£ãŠé転ãããŸã ç©è³ªã®äœ¿çšé害ã®ãããªé¢äžè¬ã®èå»¶ ãªããªã€ããããŠå€§éº»ã¯æ¥éãªã¹ã¯ãªãŒãã³ã°ã®å¿ èŠæ§ãé«ããŸãã 峿 Œãªè·å Ž è¬ç©æ€æ»ã®ããã®å®å šèŠåããã³æ¿åºã®çŸ©å äº€éæ©é¢ããã³æ³å·è¡ã®åŸæŒãã®èŠæ±ã®ãããªäŒæ¥ã ããŒããµã€ãã®ãã¹ããšãã©ã¬ã³ãžãã¯ã¢ããª... ãã£ãšèŠã
ãã¹ã¯åžå ŽèŠæš¡ãšäºæž¬ - 2026 - 2033幎äžçã®èçãã¹ã¯åžå ŽèŠæš¡ã¯äŸ¡å€ããããšæšå®ããã 2026幎ã®USD 1.45åã§ãUSD 2.67åã«éãããšäºæž¬ããã 2033幎ãŸã§ã«ãååç©ã®å¹Žéæé·ç(CAGR)ã9.3%ç»é² 2026幎ãã2033幎ãŸã§ã®äºæž¬æéããããã£ãŒã«ãã¹ã¯åžå Žã¯äžæã®çºççã«ãã£ãŠé転ãããŸã åŒåžæ¡ä»¶ç ãã°ã€ã³ é塿§èºçŸæ£ ãããŠå¿èArrestãå¢å ãã ç·æ¥ãšã¢ãŠã§ã€ç®¡çã®å¿ èŠæ§ã CPRãšCPRã®æèã®æ¡å€§ ãã¡ãŒã¹ãã¬ã¹ãã³ã¹ãã¬ãŒãã³ã°ããã°ã©ã ãã®ãããªçµç¹ããµããŒã ã¢ã¡ãªã«ã³ããŒãåäŒã¯ãå ¬å ±ããã³ãã«ã¹ã±ã¢ã®å šäœã§æ¡çšãä¿é²ããŸã... ãã£ãšèŠã
è³ã錻ãå(ENT)ãéŠãé¡ãªã©ã®é¢é£éšåãã人äœéšäœã®æ²»çãæ±ãè¬ã®é åã§ãã ENTã®å»è ã«ãã£ãŠæ±ãããå»åŠã®ç¡ç§©åºã¯æ ¢æ§ã®è³ã®äŒæãå¯éŒ»çãç¡ç ã®ã¢ãã©ã€ã¢ã³ãèŽèŠã®æå€±ãã¢ã¬ã«ã®ãŒãç ç±ãå¥äžé害ã錻çãããŸãããã³éŠçãå«ãã§ããŸãã è³ã錻åœåã®å°éå®¶ãŸãã¯è³éŒ»åœåç§å»ã¯ãäžè¬çãªæè¡åšå ·ãããã€ã¹ã䜿çšããŠæ£è ãæ²»çããããã®ç¹å®ã®ããŒã«ãæã£ãŠããŸãã ãããã®éåžžã«ã«ã¹ã¿ãã€ãºãããENTã®æ€ åã¯å¿ èŠæ§ã«åŸã£ãŠèšèšãããŠããŸã æŽåœ¢å€ç§ å¿«é©ã ENTã®æ€ åã¯3ã€ã®äž»èŠãªéšåãããªãã¡ãèéšæ®ãã座åžããã³è¶³ã®æ®ãããæã£ãŠããŸãã è³éŒ»åœåç§ã®æ€ åã¯ãããŸããŸãªæè¡äžã«æ£... ãã£ãšèŠã
ãã¥ã¬ããã»ããåžå Žã容éå¥ïŒâ€100 mLã101â150 mLã>150 mLãªã©ïŒãææå¥ïŒPVCãDEHPããªãŒPVCãªã©ïŒãæ£è ã¿ã€ãå¥ïŒå°å /æ°çå ããã³æäººïŒããšã³ããŠãŒã¶ãŒå¥ïŒç é¢ã倿¥æè¡ã»ã³ã¿ãŒïŒASCïŒãå°éã¯ãªããã¯ãªã©ïŒãæµéãã£ãã«å¥ïŒçŽæ¥/å ¥æããŒã¹ã®èª¿éã æµéæ¥è ããã³åžå£²æ¥è ããã®ä»ïŒãå°çå¥ïŒåç±³ãã©ãã³ã¢ã¡ãªã«ããšãŒããããã¢ãžã¢å€ªå¹³æŽãäžæ±ãã¢ããªã«ïŒ... ãã£ãšèŠã
éé¢ãããèåš çæµã¯ãåäžã®ãã¹ãŸãã¯åªäœãšã®å埪ç°ã«ãã£ãŠãçåå¯èœãªç¶æ ã®èåšãç¶æããããšãå«ã¿ãŸãã éé¢ãããèåšã®çæµã¯ãèºãè èããã³è³ãå«ãè€æ°ã®èåšãå«ãååžã®ç ç©¶ã§ææžåãããŠããŸãã ãããã®åé¢ãããèåšã®çæµæè¡ã«ãããååŠçæ³ã®é«æ¿åºŠããä»ã®èåšã®æŽ»åã確ä¿ããªãããæšçèåšã«å±ããããŸãã äžçäžã®èåšç§»æ€ãå¢å ãããåžå Žæé·ãå éããèŠèŸŒã¿ã§ãã äŸãã°ãèšäºã®ã³ã³ãœãŒã·ã¢ã ã«ãããš ãªãŒã¬ã³ä¿å 2018幎12æã«ã³ã«ãã¹æ¬§å·å§å¡äŒãçºè¡ããæ¬§å·(COPE)ã§ã¯ãçµæ®µéã®æ ¢æ§è èç ã®èå»¶ã¯ãè±åœã«ããã18æ³ä»¥äžã®ã°ã«ãŒãã§4.1-8%çšåºŠã§ããäžçååé¢å... ãã£ãšèŠã